AMANDA GREEN: Open Payments
NPI 1801151592 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 57 payments from 17 companies in 2025. Trend: 2023 $872 · 2024 $984 · 2025 $1,269
Food & beverage: $1,158Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $187 |
| Abbott Laboratories | 11 | $167 |
| Teva Pharmaceuticals USA, Inc. | 4 | $163 |
| Otsuka America Pharmaceutical, Inc. | 9 | $156 |
| Axsome Therapeutics, Inc. | 4 | $114 |
| ABBVIE INC. | 5 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $86 |
| Alkermes, Inc. | 3 | $85 |
| Janssen Pharmaceuticals, Inc | 1 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
Products named: CAPLYTA, PROCLAIM, Auvelity, REXULTI, VRAYLAR, TRINTELLIX, ARISTADA, ABILIFY MAINTENA.
Industry payments across GA — which companies pay providers there.
